Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III) -: Correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy

被引:30
作者
Jakob, C
Liersch, T
Meyer, W
Baretton, GB
Häusler, P
Schwabe, W
Becker, H
Aust, DE
机构
[1] Dresden Univ Technol, Inst Pathol, D-01307 Dresden, Germany
[2] Univ Gottingen, Med Ctr, Dept Gen Visceral & Transplantat Surg, D-3400 Gottingen, Germany
[3] Oncoscreen Res Inst, Jena, Germany
关键词
DPD; histopathologic tumor regression; rectal cancer; TP; TS;
D O I
10.1097/01.pas.0000170346.55304.88
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In locally advanced rectal cancer, neoadjuvant 5-fluorouracil (5-FU)-based long-term chemoradiotherapy leads to marked tumor reduction and decrease of local recurrence rate. Thymidylate synthase (TS), thymidine phosphorylase (TP), and dihydropyrimidine debydrogenase (DPD) are known to be important biomarkers to predict tumor response to 5-FU-based therapy. The aim of this study was to examine the correlation between TS, TP, and DPD protein expression and histopathologic tumor regression after neoadjuvant chemoradiotherapy. The results were compared with the recently published mRNA data. Preoperative biopsies (n = 25) and resection specimens (n = 40) from patients with rectal carcinoma (clinical UICC stage II/III) receiving neoadjuvant 5-FU-based chemoradiotherapy were studied for TS, TP, and DPD protein expression by immunohistochemistry using three different scoring systems (intensity, pattern, intensity + pattern). Results were compared with histopathologic tumor regression. A significant correlation between protein expression and tumor response was only seen when both staining intensity and staining pattern were considered. With this method, a significant association was seen between high TS expression in tumor biopsies as well as resection specimens and nonreponse of the tumor to therapy (P = 0.04). Furthermore, low TP expression in the resection specimens was significantly associated with lack of response (P = 0.02). For DPD no significant correlations were found at all. In conclusion, these results suggest that immunohistochemistry like RT-PCR is a suitable method to determine the correlation between TS, TP, and DPD expression and histopathologic tumor regression. However, precise results can only be achieved if staining intensity as well as staining pattern within the tumors are evaluated.
引用
收藏
页码:1304 / 1309
页数:6
相关论文
共 23 条
[1]   Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer [J].
Allegra, CJ ;
Parr, AL ;
Wold, LE ;
Mahoney, MR ;
Sargent, DJ ;
Johnston, P ;
Klein, P ;
Behan, K ;
O'Connell, MJ ;
Levitt, R ;
Kugler, JW ;
Tirona, MT ;
Goldberg, RM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1735-1743
[2]   Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer:: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study [J].
Allegra, CJ ;
Paik, S ;
Colangelo, LH ;
Parr, AL ;
Kirsch, I ;
Kim, G ;
Klein, P ;
Johnston, PG ;
Wolmark, N ;
Wieand, HS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :241-250
[3]   Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy [J].
Aschele, C ;
Debernardis, D ;
Casazza, S ;
Antonelli, G ;
Tunesi, G ;
Baldo, C ;
Lionetto, R ;
Maley, F ;
Sobrero, A .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1760-1770
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylase [J].
De Bruin, M ;
Van Capel, T ;
Smid, K ;
Fukushima, M ;
Hoekman, K ;
Pinedo, HM ;
Peters, GJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 491 (2-3) :93-99
[6]   Pathological features of rectal cancer after preoperative radiochemotherapy [J].
Dworak, O ;
Keilholz, L ;
Hoffmann, A .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1997, 12 (01) :19-23
[7]   Thymidylate synthase expression in colorectal cancer:: A prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy [J].
Edler, D ;
Glimelius, B ;
Hallström, M ;
Jakobsen, A ;
Johnston, PG ;
Magnusson, I ;
Ragnhammar, P ;
Blomgren, H .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1721-1728
[8]   Induction of thymidine phosphorylase by interferon and taxanes occurs only in human cancer cells with low thymidine phosphorylase activity [J].
Fukushima, M ;
Okabe, H ;
Takechi, T ;
Ichikawa, W ;
Hirayama, R .
CANCER LETTERS, 2002, 187 (1-2) :103-110
[9]   Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer [J].
Jakob, C ;
Aust, DE ;
Meyer, W ;
Baretton, GB ;
Schwabe, W ;
Häusler, P ;
Becker, H ;
Liersch, T .
JOURNAL OF PATHOLOGY, 2004, 204 (05) :562-568
[10]   Thymidylate synthase protein expression in primary colorectal cancer: Lack of correlation with outcome and response to fluorouracil in metastatic disease sites [J].
Johnston, PG ;
Benson, AB ;
Catalano, P ;
Rao, MS ;
O'Dwyer, PJ ;
Allegra, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :815-819